Business
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
Images below confirm clinical responses seen in patients with metastatic orbital (eye), temporal (brain), liver, and spine lesions No Bria-IMT™ related discontinuations reported to dateBria-IMT regimen continues under Fast Track Designation from US FDA PHILADELPHIA and VANCOUVER, British Columbia, Jan. 28, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immun
About this update from Briacell Therapeutics Corp
[{"type":"image","alt":"BriaCell Therapeutics Corp.","displaySize":"","headline":null,"caption":"BriaCell Therapeutics Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":263,"url":"https://media.zenfs.com/en/globenewswire.com/c0f690ec91d7c396d79b761df6835fd7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/VF.3uZP0Y9S.3O0ulWOxbQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM2ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/c0f690ec91d7c396d79b761df6835fd7","width":300,"height":263}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Images below confirm clinical responses seen in patients with metastatic orbital (eye), temporal (brain), liver, and spine lesions ","length":130,"tagName":"p"}]},{"val":[{"type":"text","content":"No Bria-IMT™ related discontinuations reported to date","length":54,"tagName":"p"}]},{"val":[{"type":"text","content":"Bria-IMT regimen continues under Fast Track Designation from US FDA","length":67,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":251,"olType":false},{"type":"text","content":"PHILADELPHIA and VANCOUVER, British Columbia, Jan. 28, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, releases new images highlighting resolution of metastatic breast cancer lesions in patients with orbital (eye), temporal lobe (brain), liver, and spinal involvement. Survival details on these and other select patients in its Phase 2 study, along with comparable populations, were previously reported.","length":584,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"5","style":"border-bottom:solid black 1pt;text-align:justify;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":"Table 1: Select Patients ","length":24,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"border-top:solid black 1pt;border-right:solid black 1pt;border-bottom:solid black 1pt;border-left:solid black 1pt;text-align:justify;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":"Patient/Subtype","length":15,"tagName":"p","attribs":{}}]},{"style":"border-top:solid black 1pt;border-right:solid black 1pt;border-bottom:solid black 1pt;border-left:sol...